The first diagnostic guidelines for NETs of the breast were published by Sapino et al. in 2001, which described tumors with over a 50% expression of neuroendocrine markers (synaptophysin and chromogranin) as primary neuroendocrine tumors of the breast [6]. This evidence concerns the gene SYP and breast neuroendocrine neoplasm.